To validate the effect of methylation on the expression of IRF1, we treated RCC cells with the methylation inhibitor, decitibine (DAC), and found that the mRNA and protein levels of IRF1 and PD-L1 were elevated after DAC treatment (Fig. 6A and 6B). The gene discussed is IRF1; the disease is renal cell carcinoma.